NCT04717024招募中不适用
The Nanowear Wearable Covid-19 Observational and Analysis Trend
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Hosptialized patient data
研究概览
简要总结
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject has provided informed consent
- •Male or female over the age of 18 years
- •The patient is currently hospitalized with a primary diagnosis of Covid-19
排除标准
- •Subject is unwilling or unable to wear the vest during hospitalization.
- •Subjects who are pregnant.
- •Subject is intubated or admitted to ICU
- •Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
结局指标
主要结局
Hosptialized patient data
时间窗: up to 30 days of monitoring leading to discharge or admission to ICU
The primary study endpoint is adequate collection of hospitalized COVID 19 patient health metric data through the Nanowear WMDRS
次要结局
- Trends in COVID 19 exacerbation(up to 30 days of monitoring leading to discharge or admission to ICU)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Nanowear Heart Failure Management Multi-sensor AlgorithmHeart FailureNCT03719079Nanowear Inc.500
已完成
不适用
COVID-19 Surveillance Based on Smart Wearable DeviceCOVID-19NCT04459637Peking University First Hospital103
终止
不适用
Clinical Feasibility of a Non-invasive Wearable Acoustic Device for Measuring Air Trapping in COPDCOPDCOPD ExacerbationNCT04450368Respira Labs, Inc8
已完成
不适用
COVID Breath Test - AnconCovid19NCT04760639Medical University of South Carolina100
终止
不适用
The Nanowear Wearable System SimpleSense Validation Trial for Cardiac OutputRight Heart CatheterizationNCT05629533Nanowear Inc.13